Basal and Bolus Insulin Dose Changes after Switching Basal Insulin to Insulin Degludec in Patients with Type 1 DiabetesMellitus: A Pilot Study

Basal and Bolus Insulin Dose Changes after Switching Basal Insulin to Insulin Degludec in... Clin Drug Investig (2017) 37:845–852 DOI 10.1007/s40261-017-0541-0 ORIGINAL RESEARCH ARTICLE Basal and Bolus Insulin Dose Changes after Switching Basal Insulin to Insulin Degludec in Patients with Type 1 Diabetes Mellitus: A Pilot Study 1,3 1 1 1 • • • • Yoshiyuki Hamamoto Sachiko Honjo Kanta Fujimoto Shinsuke Tokumoto 1,2 1 1 • • Hiroki Ikeda Yoshiharu Wada Hiroyuki Koshiyama Published online: 17 June 2017 Springer International Publishing Switzerland 2017 Abstract switched from once-daily BI (21.7 ± 8.3 to 19.3 ± 8.8 Background and objectives Ultra-long-acting insulin U/day, p = 0.016) especially in the injection before degludec (DEG) has a longer duration of action and less breakfast and evening meal. Body weight and hypo- daily variability relative to other basal insulin (BI), and glycemia frequency was not significantly different. thus may benefit patients with type 1 diabetes mellitus Conclusion DEG improved glycemic control when swit- (T1DM). We examined the impact of switching BI to DEG ched from once-daily BI and maintained glycemic control on glycemic control and insulin dose in T1DM. when switched from twice-daily BI without increasing Methods T1DM patients (n = 22; six male; mean age: hypoglycemia. 64.5 ± 12.6 years) receiving basal-bolus insulin therapy were included. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Clinical Drug Investigation Springer Journals

Basal and Bolus Insulin Dose Changes after Switching Basal Insulin to Insulin Degludec in Patients with Type 1 DiabetesMellitus: A Pilot Study

Loading next page...
 
/lp/springer_journal/basal-and-bolus-insulin-dose-changes-after-switching-basal-insulin-to-m0bvUzunKk
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Springer International Publishing Switzerland
Subject
Medicine & Public Health; Pharmacotherapy; Pharmacology/Toxicology; Internal Medicine
ISSN
1173-2563
eISSN
1179-1918
D.O.I.
10.1007/s40261-017-0541-0
Publisher site
See Article on Publisher Site

Abstract

Clin Drug Investig (2017) 37:845–852 DOI 10.1007/s40261-017-0541-0 ORIGINAL RESEARCH ARTICLE Basal and Bolus Insulin Dose Changes after Switching Basal Insulin to Insulin Degludec in Patients with Type 1 Diabetes Mellitus: A Pilot Study 1,3 1 1 1 • • • • Yoshiyuki Hamamoto Sachiko Honjo Kanta Fujimoto Shinsuke Tokumoto 1,2 1 1 • • Hiroki Ikeda Yoshiharu Wada Hiroyuki Koshiyama Published online: 17 June 2017 Springer International Publishing Switzerland 2017 Abstract switched from once-daily BI (21.7 ± 8.3 to 19.3 ± 8.8 Background and objectives Ultra-long-acting insulin U/day, p = 0.016) especially in the injection before degludec (DEG) has a longer duration of action and less breakfast and evening meal. Body weight and hypo- daily variability relative to other basal insulin (BI), and glycemia frequency was not significantly different. thus may benefit patients with type 1 diabetes mellitus Conclusion DEG improved glycemic control when swit- (T1DM). We examined the impact of switching BI to DEG ched from once-daily BI and maintained glycemic control on glycemic control and insulin dose in T1DM. when switched from twice-daily BI without increasing Methods T1DM patients (n = 22; six male; mean age: hypoglycemia. 64.5 ± 12.6 years) receiving basal-bolus insulin therapy were included.

Journal

Clinical Drug InvestigationSpringer Journals

Published: Jun 17, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off